BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26936507)

  • 21. Identification and activation of Src family kinases in primary megakaryocytes.
    Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
    Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylation of I-kappa B kinase alpha/beta by protein kinase C-dependent c-Src activation is involved in TNF-alpha-induced cyclooxygenase-2 expression.
    Huang WC; Chen JJ; Inoue H; Chen CC
    J Immunol; 2003 May; 170(9):4767-75. PubMed ID: 12707358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.
    Ong L; Morison IM; Ledgerwood EC
    Br J Haematol; 2017 Jan; 176(2):268-279. PubMed ID: 27861742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RACK1: a novel substrate for the Src protein-tyrosine kinase.
    Chang BY; Harte RA; Cartwright CA
    Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5'-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I.
    Prasad N; Topping RS; Decker SJ
    J Cell Sci; 2002 Oct; 115(Pt 19):3807-15. PubMed ID: 12235291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.
    Stritt S; Nurden P; Turro E; Greene D; Jansen SB; Westbury SK; Petersen R; Astle WJ; Marlin S; Bariana TK; Kostadima M; Lentaigne C; Maiwald S; Papadia S; Kelly AM; Stephens JC; Penkett CJ; Ashford S; Tuna S; Austin S; Bakchoul T; Collins P; Favier R; Lambert MP; Mathias M; Millar CM; Mapeta R; Perry DJ; Schulman S; Simeoni I; Thys C; ; Gomez K; Erber WN; Stirrups K; Rendon A; Bradley JR; van Geet C; Raymond FL; Laffan MA; Nurden AT; Nieswandt B; Richardson S; Freson K; Ouwehand WH; Mumford AD
    Blood; 2016 Jun; 127(23):2903-14. PubMed ID: 26912466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel MPIG6B gene mutation in an adolescent girl with congenital thrombocytopenia and myelofibrosis.
    Wang Z; Tao F; Yang L; Song N; Teng J; Lu W; Qi S; Chen Z; Xiong H
    Curr Res Transl Med; 2022 Sep; 70(4):103355. PubMed ID: 35940081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis.
    Åström M; Hahn-Strömberg V; Zetterberg E; Vedin I; Merup M; Palmblad J
    Am J Hematol; 2015 Mar; 90(3):E44-8. PubMed ID: 25421114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyrosine Phosphorylation Regulates Plasma Membrane Expression and Stability of the Human Bile Acid Transporter ASBT (
    Chothe PP; Czuba LC; Ayewoh EN; Swaan PW
    Mol Pharm; 2019 Aug; 16(8):3569-3576. PubMed ID: 31194565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The gray platelet syndrome: clinical spectrum of the disease.
    Nurden AT; Nurden P
    Blood Rev; 2007 Jan; 21(1):21-36. PubMed ID: 16442192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src-family protein tyrosine kinase phosphorylates WNK4 and modulates its inhibitory effect on KCNJ1 (ROMK).
    Lin DH; Yue P; Yarborough O; Scholl UI; Giebisch G; Lifton RP; Rinehart J; Wang WH
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4495-500. PubMed ID: 25805816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of the phosphatase PTPROt at Tyr
    Roth L; Wakim J; Wasserman E; Shalev M; Arman E; Stein M; Brumfeld V; Sagum CA; Bedford MT; Tuckermann J; Elson A
    Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.
    Kubota Y; Tanaka T; Kitanaka A; Ohnishi H; Okutani Y; Waki M; Ishida T; Kamano H
    EMBO J; 2001 Oct; 20(20):5666-77. PubMed ID: 11598010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
    Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
    Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
    Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
    Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine phosphorylation of beta2-chimaerin by Src-family kinase negatively regulates its Rac-specific GAP activity.
    Kai M; Yasuda S; Imai S; Kanoh H; Sakane F
    Biochim Biophys Acta; 2007 Sep; 1773(9):1407-15. PubMed ID: 17560670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton.
    Obergfell A; Eto K; Mocsai A; Buensuceso C; Moores SL; Brugge JS; Lowell CA; Shattil SJ
    J Cell Biol; 2002 Apr; 157(2):265-75. PubMed ID: 11940607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin enhances megakaryopoiesis and proplatelet formation via p-Erk1/2 and F-actin reorganization.
    Ye JY; Liang EY; Cheng YS; Chan GC; Ding Y; Meng F; Ng MH; Chong BH; Lian Q; Yang M
    Stem Cells; 2014 Nov; 32(11):2973-82. PubMed ID: 24980849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dominant-negative GFI1B mutation in the gray platelet syndrome.
    Monteferrario D; Bolar NA; Marneth AE; Hebeda KM; Bergevoet SM; Veenstra H; Laros-van Gorkom BA; MacKenzie MA; Khandanpour C; Botezatu L; Fransen E; Van Camp G; Duijnhouwer AL; Salemink S; Willemsen B; Huls G; Preijers F; Van Heerde W; Jansen JH; Kempers MJ; Loeys BL; Van Laer L; Van der Reijden BA
    N Engl J Med; 2014 Jan; 370(3):245-53. PubMed ID: 24325358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.